Suppr超能文献

健康视网膜中对同基因、同种异体和异种基质细胞移植物的免疫识别。

Immune recognition of syngeneic, allogeneic and xenogeneic stromal cell transplants in healthy retinas.

机构信息

Experimental Ophthalmology Group, Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca) & Universidad de Murcia, Murcia, Spain.

Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, Antwerp, Belgium.

出版信息

Stem Cell Res Ther. 2022 Aug 20;13(1):430. doi: 10.1186/s13287-022-03129-y.

Abstract

BACKGROUND

Advanced therapies using adult mesenchymal stromal cells (MSCs) for neurodegenerative diseases are not effectively translated into the clinic. The cross talk between the transplanted cells and the host tissue is something that, despite its importance, is not being systematically investigated.

METHODS

We have compared the response of the mouse healthy retina to the intravitreal transplantation of MSCs derived from the bone marrow in four modalities: syngeneic, allogeneic, xenogeneic and allogeneic with immunosuppression using functional analysis in vivo and histology, cytometry and protein measurement post-mortem. Data were considered significant (p < 0.05) after nonparametric suitable statistical tests.

RESULTS

Transplanted cells remain in the vitreous and are cleared by microglial cells a process that is quicker in allotransplants regardless of immunosuppression. All transplants cause anatomical remodelling which is more severe after xenotransplants. Xeno- and allotransplants with or without immunosuppression cause macro- and microglial activation and retinal functional impairment, being xenotransplants the most detrimental and the only ones that recruit CD45Iba1cells. The profile of proinflammatory cytokines changes in all transplantation settings. However, none of these changes affect the retinal ganglion cell population.

CONCLUSIONS

We show here a specific functional and anatomical retinal response depending on the MSC transplantation modality, an aspect that should be taken into consideration when conducting preclinical studies if we intend a more realistic translation into clinical practice.

摘要

背景

利用成人间充质基质细胞(MSCs)治疗神经退行性疾病的先进疗法尚未有效地转化为临床应用。尽管其重要性不言而喻,但细胞移植与宿主组织之间的相互作用尚未得到系统研究。

方法

我们比较了骨髓来源的 MSC 以四种方式(同基因、同种异基因、异种和同种异体加免疫抑制)经玻璃体内移植到健康的小鼠视网膜后的反应,通过体内功能分析和组织学、细胞术以及死后的蛋白测量进行评估。对适合非参数统计检验的数据进行了显著性(p<0.05)检验。

结果

无论是否进行免疫抑制,移植细胞都保留在玻璃体内并被小胶质细胞清除,同种异体移植清除更快。所有同种异体移植都会引起解剖重塑,异种移植后更为严重。无论是否进行免疫抑制,异种和同种异体移植都会引起巨细胞和小胶质细胞激活以及视网膜功能障碍,其中异种移植的损伤最大,是唯一募集 CD45Iba1 细胞的移植方式。所有移植设置中的促炎细胞因子谱均发生改变。然而,这些变化都没有影响视网膜神经节细胞群体。

结论

我们在此展示了一种依赖于 MSC 移植方式的特定的视网膜功能和解剖学反应,在进行临床前研究时,如果我们希望更真实地转化为临床实践,就应该考虑这一方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3999/9392272/b5b64451d19c/13287_2022_3129_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验